Opioid Recovery: Eliminating Costs for Treatment and Support
The MORE Savings Act was sent to three different House committees on September 3, 2026. It has not moved since that date and remains in the early stages of the legislative process. The bill must receive a vote or approval from these committees before it can move forward.
While addressing the opioid crisis is a bipartisan goal, mandating that private insurers provide services with zero cost-sharing often faces significant political and industry opposition.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Small businesses that sponsor group health plans would be required to cover opioid treatment, overdose reversal drugs, and recovery services without any cost-sharing starting in 2027. While this could modestly raise plan costs passed on through premiums, it also reduces employer costs tied to untreated addiction such as absenteeism and lost productivity.
“A group health plan shall, at a minimum, with respect to a participant or beneficiary in the plan, provide coverage for and shall not impose any cost-sharing requirements for”
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
MORE Savings Act
Analysis generated by AI. Always verify with official sources.